Trial Profile
A retrospective, observational study of Zostavax®, a herpes zoster (HZ) vaccine, in a Privately Insured Population Aged ≥60 years during 2007-2013.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Therapeutic Use
- 18 Dec 2015 New trial record